Interview with Jacek Barlinski, Country Manager, Nycomed Poland
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
Address: ul. Cybernetyki 7B Warszawa 02-677,Poland
Tel: +48 22 566 21 00
Web: http://www.berlin-chemie.com/International/BERLIN-CHEMIE-locations/Poland
BERLIN-CHEMIE is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company.
MENARINI pursues two strategic objectives: research and internationalisation. Both endeavours enable innovative products to be used successfully to the satisfaction of patients throughout the world. The MENARINI Group enjoys an outstanding reputation worldwide as an efficient and reliable partner. This applies both to the development of new drugs and to the communication of scientific insights.
BERLIN-CHEMIE also benefits from this partnership-based way of thinking. We consistently carry on the group strategy in our remit.
BERLIN-CHEMIE AG has a long drug-manufacturing tradition and access to a highly motivated, excellently trained production team.
We produce solid dosage forms (tablets, film-coated tablets, capsules), liquids (solution and drops), suppositories, as well as solutions for infusion at the Adlershof and Britz production sites in Berlin.
These production facilities have been completely modernised to the highest technological standards and enable us to guarantee an efficient finishing of high-quality drugs.
A new unit compliant with the highest standards was installed for the production of solutions for infusion in 2000 at the Adlershof site. In 2001, a new unit for the production of oral liquids was introduced.
A modern production building with 11 production lines for the packaging of tablets, capsules and film-coated tablets was opened in April 2003.
Per year, around 270 million package units of drugs are produced by 339 staff. These drugs are used around the world to treat disease.
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How has Poland alone…
You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year. The market size is over five billion Euros which makes…
In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your…
Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was…
For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to…
Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in…
With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases. Genzyme operates in the genetic market,…
Until very recently originator drugs had a very weak presence in central and east European countries including Poland, and there was no real patent legislation. Nevertheless, Poland has changed and…
The group has significantly invested in Poland. Are you today generally satisfied with the initial and follow up investments from Mediq in the country? The group has been present in…
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
See our Cookie Privacy Policy Here